Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Permanently Discontinued

EPTIFIBATIDE INJECTION

TEVA CANADA LIMITED

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is EPTIFIBATIDE INJECTION discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that EPTIFIBATIDE INJECTION 0.75MG has been permanently discontinued (last updated June 27, 2017). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is EPTIFIBATIDE INJECTION not available?

The reason the manufacturer reported: Manufacturing issues.

Can I still get this?Possibly — same-ingredient product records found
StatusPermanently Discontinued
Same-ingredient products on file1 product
Affected strength0.75MG
Last updated2017-06-27

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

EPTIFIBATIDE INJECTION

FRESENIUS KABI CANADA LTD

2MG · DIN 02460386

Different strengthSame dosage formSame routeNo current shortage

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02405083

Strength

0.75MG

Dosage Form

SOLUTION

Route

INTRAVENOUS

Active Ingredient

EPTIFIBATIDE

Tier

Unrated

Last Updated

2017-06-27

Reason for Shortage

Manufacturing issues

Past Reports for This Drug

EPTIFIBATIDE INJECTION has 2 shortage/discontinuation reports on file — this is one of them.